Anjela Galan, MD
Associate Professor of Dermatology and Pathology; Associate Director, Dermatopathology Fellowship
Research & Publications
Biography
News
Coauthors
Selected Publications
- 08. Proteomic Profiling of Tumor Microenvironment In Desmoplastic Melanoma Using The Nanostring Geomx Digital Spatial ProfilerSu D, Galan A, Schoenfeld D, Ibrahim W, Cabrejo R, Baumann R, Rimm D, Khan S, Kluger H, Olino K, Clune J. 08. Proteomic Profiling of Tumor Microenvironment In Desmoplastic Melanoma Using The Nanostring Geomx Digital Spatial Profiler. Plastic & Reconstructive Surgery Global Open 2024, 12: 6-6. PMCID: PMC11041221, DOI: 10.1097/01.gox.0001015124.74133.52.
- Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanomaSu D, Schoenfeld D, Ibrahim W, Cabrejo R, Djureinovic D, Baumann R, Rimm D, Khan S, Halaban R, Kluger H, Olino K, Galan A, Clune J. Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma. Journal For ImmunoTherapy Of Cancer 2024, 12: e008646. PMID: 38519058, PMCID: PMC10961546, DOI: 10.1136/jitc-2023-008646.
- 1437 Proteomic profiling of tumor microenvironment in desmoplastic melanoma using the nanostring geomx digital spatial profilerSu D, Schoenfeld D, Ibrahim W, Baumann R, Rimm D, Kluger H, Olino K, Galan A, Clune J. 1437 Proteomic profiling of tumor microenvironment in desmoplastic melanoma using the nanostring geomx digital spatial profiler. 2023, a1600-a1600. DOI: 10.1136/jitc-2023-sitc2023.1437.
- Predictive accuracy of elevated mitotic rate on lymph node positivity and recurrence in thin melanomasLy C, Blaha O, Wei W, Galan A, Kluger H, Ariyan S, Olino K, Clune J. Predictive accuracy of elevated mitotic rate on lymph node positivity and recurrence in thin melanomas. Frontiers In Oncology 2023, 12: 1077226. PMID: 36686728, PMCID: PMC9853390, DOI: 10.3389/fonc.2022.1077226.
- 103 JAK-STAT activation in anti-PD-1 therapy-associated granuloma annulareChoi R, Wang J, Damsky W, Wang A, Galan A, Leventhal J. 103 JAK-STAT activation in anti-PD-1 therapy-associated granuloma annulare. Journal Of Investigative Dermatology 2022, 142: s18. DOI: 10.1016/j.jid.2022.05.038.
- ASO Visual Abstract: Merkel Cell Carcinoma—Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and NationallyEsposito A, Jacobs D, Ariyan S, Galan A, Kluger H, Clune J, Weiss S, Tran T, Olino K. ASO Visual Abstract: Merkel Cell Carcinoma—Changing Practice Patterns and Impact on Recurrence-Free and Overall Survival at a Single Institution and Nationally. Annals Of Surgical Oncology 2021, 28: 736-737. DOI: 10.1245/s10434-021-10784-7.
- Abstract 139: Prognostic Factors In Determining The Recurrence Of Desmoplastic MelanomaPersing S, Cabrejo R, Galan A, Ariyan S, Clune J. Abstract 139: Prognostic Factors In Determining The Recurrence Of Desmoplastic Melanoma. Plastic & Reconstructive Surgery Global Open 2019, 7: 97-97. PMCID: PMC6504427, DOI: 10.1097/01.gox.0000558413.43554.9b.
- 168 Nephrogenic systemic fibrosisGalan A, Cowper S. 168 Nephrogenic systemic fibrosis. 2018, 557-558. DOI: 10.1016/b978-0-7020-6912-3.00168-3.
- Pathology and Molecular Features of Melanocytic Nevi and MelanomaGalan A. Pathology and Molecular Features of Melanocytic Nevi and Melanoma. 2017 DOI: 10.1891/9781617052958.0002.
- Nodular plaque in a cardiac transplant patientWaldman A, Ezaldein H, Tomayko M, Galan A. Nodular plaque in a cardiac transplant patient. Journal Of The American Academy Of Dermatology 2015, 72: e111-e112. DOI: 10.1016/j.jaad.2014.12.037.
- ReplyGalan A, McNiff J. Reply. Journal Of Cutaneous Pathology 2008, 35: 1164-1164. DOI: 10.1111/j.1600-0560.2007.00951.x.
- GLI2 Does not Distinguish Between Basal Cell Carcinoma and Benign Adnexal TumorsGalan A, Lazova R. GLI2 Does not Distinguish Between Basal Cell Carcinoma and Benign Adnexal Tumors. American Journal Of Dermatopathology 2006, 28: 230. DOI: 10.1097/00000372-200606000-00022.